ProtAffin wins orphan designation for anti-inflammatory drug
ProtAffin’s PA401 has been granted orphan medicinal product designation in the EU for the ‘prevention of delayed graft function after solid organ transplantation’. PA401 is ProtAffin’s lead anti-inflammatory
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.